Jazz Pharmaceuticals
JAZZ
#1373
Rank
A$23.84 B
Marketcap
A$371.41
Share price
2.93%
Change (1 day)
33.92%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): A$0.38 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$4.71 Billion. In 2025 the company made an earning of -A$0.95 Billion a decrease over its 2024 earnings that were of A$0.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.38 B-141.23%
2025 -A$0.95 Billion-233.5%
2024 A$0.70 B57.87%
2023 A$0.44 B-179.92%
2022 -A$0.56 Billion230.37%
2021 -A$0.17 Billion-141.02%
2020 A$0.41 B-39.45%
2019 A$0.68 B-14.2%
2018 A$0.79 B20.03%
2017 A$0.66 B-17.15%
2016 A$0.79 B22.14%
2015 A$0.65 B187.64%
2014 A$0.22 B-50.79%
2013 A$0.46 B73.63%
2012 A$0.26 B41.69%
2011 A$0.18 B116.61%
2010 A$86.62 M262.77%
2009 A$23.87 M-111.33%
2008 -A$0.22 Billion1.31%
2007 -A$0.21 Billion77.8%
2006 -A$0.12 Billion36.59%
2005 -A$85.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$18.95 B 4,766.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$3.14 B 707.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.59 Billion-1,020.78%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$1.83 B 371.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel